HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Israel J. Jacobowitz Daniel M. Rose Mark W. Connolly Anthony J. Acinapura Zvi Zisbrod Kok Hoo Lim Joseph N. Cunningham, Jr. Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gelbfish, J. Articles by Cunningham, J. N. Search for Related Content PubMed PubMed Citation Articles by Gelbfish, J. Articles by Cunningham, J. N., Jr.

Ann Thorac Surg 1986;42:70-73
© 1986 The Society of Thoracic Surgeons

---

Articles

Cryopreserved Homologous Saphenous Vein: Early and Late Patency in Coronary Artery Bypass Surgical Procedures

From the Departments of Thoracic and Cardiovascular Surgery, Maimonides Medical Center, Brooklyn, NY

Accepted for publication October 26, 1985.

^* Address reprint requests to Dr. Cunningham, Department of Surgery, Maimonides Medical Center, 4802 Tenth Avenue, Brooklyn, NY 11219

Autologous saphenous vein has proved to be a satisfactory conduit for use in coronary artery bypass grafting. Unfortunately, it is not always available, and substitute material must sometimes be used. When satisfactory autologous veins were not available and the internal mammary arteries were unsuitable, cryopreserved homologous saphenous veins were used in 28 patients. A total of 76 grafts were constructed. Cryopreserved homologous veins were used for 61 grafts, autologous saphenous veins for 11 grafts, and the internal mammary artery for 2 grafts. Coronary angiography was performed 8 to 12 days postoperatively in 16 patients. Of the 31 homografts studied, 8 were occluded (26%), 3 were stenotic (9%), and 20 were normal (65%). The one internal mammary artery and six autologous veins studied were all patent. Six patients underwent late catheterization 6 to 12 months postoperatively. Thirteen homografts were studied at late catheterization: 11 were occluded, 1 was severely stenotic, and 1 was mildly stenotic. At late catheterization, the one internal mammary artery studied was patent, and the one autologous saphenous vein was 95% occluded. Results of both early and late catheterization performed on 18 patients demonstrated that of the 35 homografts studied, 17 (49%) were occluded, 3 (9%) had greater than 70% stenosis, 1 (3%) had mild disease, and 14 (40%) were free of disease. One year follow-up data obtained on 26 patients revealed that 4 patients (15%) died of cardiac causes, 2 patients (8%) died of noncardiac causes, 11 patients (42%) have recurrent angina, and 9 (35%) are asymptomatic.

It is concluded that use of cryopreserved homologous saphenous veins for coronary artery bypass grafting should be avoided if at all possible.

This article has been cited by other articles:

				H. Kerdjoudj, N. Berthelemy, S. Rinckenbach, A. Kearney-Schwartz, K. Montagne, P. Schaaf, P. Lacolley, J.-F. Stoltz, J.-C. Voegel, and P. Menu Small Vessel Replacement by Human Umbilical Arteries With Polyelectrolyte Film-Treated Arteries: In Vivo Behavior J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1589 - 1597. [Abstract] [Full Text] [PDF]

				P. Lamm, G. Juchem, S. Milz, M. Schuffenhauer, and B. Reichart Autologous Endothelialized Vein Allograft: A Solution in the Search for Small-Caliber Grafts in Coronary Artery Bypass Graft Operations Circulation, September 18, 2001; 104(2009): I-108 - I-114. [Abstract] [Full Text] [PDF]

				H. Moriyama, T. Sasajima, S. Hirata, K. Yamazaki, E. Yatsuyanagi, and Y. Kubo Revascularization of canine cryopreserved tracheal allografts Ann. Thorac. Surg., June 1, 2000; 69(6): 1701 - 1706. [Abstract] [Full Text] [PDF]

				P. Lamm, G. Juchem, P. Weyrich, S. Nees, and B. Reichart NEW ALTERNATIVE CORONARY BYPASS GRAFT: FIRST CLINICAL EXPERIENCE WITH AN AUTOLOGOUS ENDOTHELIALIZED CRYOPRESERVED ALLOGRAFT J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1217 - 1219. [Full Text] [PDF]

				E. Wagner, R. Roy, Y. Marois, Y. Douville, and R. Guidoin FRESH VENOUS ALLOGRAFTS IN PERIPHERAL ARTERIAL RECONSTRUCTION IN DOGSEffects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1732 - 1744. [Abstract] [Full Text]

				S. Slutzki, D. Jaffe, M. Nessing, H. Bogokowsky, and A. Halevy Homologous Cryopreserved Saphenous Vein for Construction of a "Jump" Arterioarterial Access for Hemodialysis--A Case Report Vascular and Endovascular Surgery, May 1, 1993; 27(4): 316 - 319. [Abstract] [PDF]

				H. B. Barner Allogenic vein as a conduit for coronary artery bypass Ann. Thorac. Surg., November 1, 1992; 54(5): 817 - 817. [Abstract] [PDF]

				G. W. Laub, S. Muralidharan, R. Clancy, W. J. Eldredge, C. Chen, M. S. Adkins, J. Fernandez, W. A. Anderson, and L. B. McGrath Cryopreserved allograft veins as alternative coronary artery bypass conduits: Early phase results Ann. Thorac. Surg., November 1, 1992; 54(5): 826 - 831. [Abstract] [PDF]

				K.G.M. Brockbank, J.F. Carpenter, L.B. Schwartz, C. Nardiello, and P.-O. Hagen Smooth Muscle Function in Short- and Long-term Stored Cryopreserved Veins Vascular and Endovascular Surgery, March 1, 1992; 26(2): 116 - 122. [Abstract] [PDF]